Advertisement
Original research| Volume 21, ISSUE 7, P654-660, July 2018

Download started.

Ok

Tramadol effects on physical performance and sustained attention during a 20-min indoor cycling time-trial: A randomised controlled trial

Published:November 07, 2017DOI:https://doi.org/10.1016/j.jsams.2017.10.032

      Abstract

      Objectives

      To investigate the effect of tramadol on performance during a 20-min cycling time-trial (Experiment 1), and to test whether sustained attention would be impaired during cycling after tramadol intake (Experiment 2).

      Design

      Randomized, double-blind, placebo controlled trial.

      Methods

      In Experiment 1, participants completed a cycling time-trial, 120-min after they ingested either tramadol or placebo. In Experiment 2, participants performed a visual oddball task during the time-trial. Electroencephalography measures (EEG) were recorded throughout the session.

      Results

      In Experiment 1, average time-trial power output was higher in the tramadol vs. placebo condition (tramadol: 220 W vs. placebo: 209 W; p < 0.01). In Experiment 2, no differences between conditions were observed in the average power output (tramadol: 234 W vs. placebo: 230 W; p > 0.05). No behavioural differences were found between conditions in the oddball task. Crucially, the time frequency analysis in Experiment 2 revealed an overall lower target-locked power in the beta-band (p < 0.01), and higher alpha suppression (p < 0.01) in the tramadol vs. placebo condition. At baseline, EEG power spectrum was higher under tramadol than under placebo in Experiment 1 while the reverse was true for Experiment 2.

      Conclusions

      Tramadol improved cycling power output in Experiment 1, but not in Experiment 2, which may be due to the simultaneous performance of a cognitive task. Interestingly enough, the EEG data in Experiment 2 pointed to an impact of tramadol on stimulus processing related to sustained attention.

      Trial registration

      EudraCT number: 2015-005056-96.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Science and Medicine in Sport
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bastami S.
        • Haage P.
        • Kronstrand R.
        • et al.
        Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
        Forensic Sci Int. 2014; 238: 125-132https://doi.org/10.1016/j.forsciint.2014.03.003
        • Bastian B.
        • Jetten J.
        • Hornsey M.J.
        • et al.
        The positive consequences of pain: a biopsychosocial approach.
        Pers Soc Psychol Rev. 2014; 18: 256-279https://doi.org/10.1177/1088868314527831
        • Mauger A.R.
        • Jones A.M.
        • Williams C.A.
        Influence of acetaminophen on performance during time trial cycling.
        J Appl Physiol. 2010; 108: 98-104https://doi.org/10.1152/japplphysiol.00761.2009
        • Ionescu A.M.
        • Manolescu B.N.
        • Popa R.
        • et al.
        Effects of tramadol treatment on aerobic exercise capacity in subjects with chronic non-specific low back pain.
        Palestrica Third Millenn – Civiliz Sport. 2015; 16: 214-218
        • Mintzer M.Z.
        • Lanier R.K.
        • Lofwall M.R.
        • et al.
        Effects of repeated tramadol and morphine administration on psychomotor and cognitive performance in opioid-dependent volunteers.
        Drug Alcohol Depend. 2010; 111: 265-268https://doi.org/10.1016/j.drugalcdep.2010.05.002
        • Thürauf N.
        • Fleischer W.K.
        • Liefhold J.
        • et al.
        Dose dependent time course of the analgesic effect of a sustained-release preparation of tramadol on experimental phasic and tonic pain.
        Br J Clin Pharmacol. 1996; 41: 115-123
      1. Robinson J, Germano S. The painkiller that cycling wants to see banned - WSJ. Wall St J. Available at: http://www.wsj.com/articles/the-painkiller-that-cycling-wants-to-ban-1476456216. Accessed 19 December 2016.

        • Loraschi A.
        • Galli N.
        • Cosentino M.
        Dietary supplement and drug use and doping knowledge and attitudes in Italian young elite cyclists.
        Clin J Sport Med. 2013; 0: 1-7https://doi.org/10.1097/JSM.0000000000000018
      2. Cary T. Team Sky deny Michael Barry’s claim they ride on painkiller Tramadol - Telegraph. Available at: http://www.telegraph.co.uk/sport/othersports/cycling/10794325/Team-Sky-deny-Michael-Barrys-claim-they-ride-on-painkiller-Tramadol.html. Accessed 17 December 2016.

      3. WADA. The 2017 Monitoring Program. World Anti-Doping Agency. Available at: https://wada-main-prod.s3.amazonaws.com/resources/files/wada-2017-monitoring-program-en.pdf.

      4. Anti-doping Agency US. Tramadol Why Some Athletes and Experts Want It Banned. USADA. Available at: https://www.usada.org/tramadol-why-some-athletes-and-anti-doping-experts-want-it-banned/. Accessed 30 May 2017.

        • Perez-Lloret S.
        • Videla A.J.
        • Richaudeau A.
        • et al.
        A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention, and poor academic performance: an exploratory cross-sectional study in teenagers.
        J Clin Sleep Med. 2013; 9: 469-473https://doi.org/10.5664/jcsm.2668
        • Faul F.
        • Erdfelder E.
        • Buchner A.
        • et al.
        Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses.
        Behav Res Methods. 2009; 41: 1149-1160https://doi.org/10.3758/BRM.41.4.1149
        • Lucía A.
        • Rabadán M.
        • Hoyos J.
        • et al.
        Frequency of the V·O2max plateau phenomenon in world-class cyclists.
        Int J Sports Med. 2006; 27: 984-992https://doi.org/10.1055/s-2006-923833
        • Sawaki R.
        • Katayama J.
        Difficulty of discrimination modulates attentional capture for deviant information.
        Psychophysiology. 2007; 44: 374-382https://doi.org/10.1111/j.1469-8986.2007.00506.x
        • Andrade E.
        • Arce C.
        • Seaone G.
        Adaptación al español del cuestionario «Perfil de los Estados de Ánimo» en una muestra de deportistas.
        Psicothema. 2002; 14: 708-713
        • Simons C.J.P.
        • Sambeth A.
        • Krabbendam L.
        • et al.
        Auditory P300 and N100 components as intermediate phenotypes for psychotic disorder: familial liability and reliability.
        Clin Neurophysiol. 2011; 122: 1984-1990https://doi.org/10.1016/j.clinph.2011.02.033
        • Lee K.A.
        • Hicks G.
        • Nino-Murcia G.
        Validity and reliability of a scale to measure fatigue.
        Psychiatry Res. 1990; 36: 291-298https://doi.org/10.1016/0165-1781(91)90027-M
        • Delorme A.
        • Makeig S.
        EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis.
        J Neurosci Methods. 2004; 134: 9-21https://doi.org/10.1016/j.jneumeth.2003.10.009
        • Oostenveld R.
        • Fries P.
        • Maris E.
        • et al.
        FieldTrip: open source software for advanced analysis of MEG, EEG, and invasive electrophysiological data.
        Comput Intell Neurosci. 2011; 2011 (156869)https://doi.org/10.1155/2011/156869
        • Hoffmann S.
        • Falkenstein M.
        The correction of eye blink artefacts in the EEG: a comparison of two prominent methods.
        PLoS One. 2008; 3e3004https://doi.org/10.1371/journal.pone.0003004
        • Pesarin F.
        • Salmaso L.
        Wiley InterScience (online service).
        Permutation Tests for Complex Data: Theory, Applications, and Software. Wiley, 2010
        • Pesarin F.
        • Salmaso L.
        The permutation testing approach: a review.
        Statistica. 2010; 70: 481-509https://doi.org/10.6092/issn.1973-2201/3599
        • Maris E.
        • Oostenveld R.
        Nonparametric statistical testing of EEG- and MEG-data.
        J Neurosci Methods. 2007; 164: 177-190https://doi.org/10.1016/j.jneumeth.2007.03.024
        • Foster J.
        • Taylor L.
        • Chrismas B.C.R.
        • et al.
        The influence of acetaminophen on repeated sprint cycling performance.
        Eur J Appl Physiol. 2014; 114: 41-48https://doi.org/10.1007/s00421-013-2746-0
        • Peng W.
        • Hu Y.
        • Mao Y.
        • et al.
        Widespread cortical alpha-ERD accompanying visual oddball target stimuli is frequency but non-modality specific.
        Behav Brain Res. 2015; 295: 71-77https://doi.org/10.1016/j.bbr.2015.04.051
        • McCormick A.
        • Meijen C.
        • Marcora S.
        Psychological determinants of whole-body endurance performance.
        Sport Med. 2015; 45: 997-1015https://doi.org/10.1007/s40279-015-0319-6
        • Clayton M.S.
        • Yeung N.
        • Cohen Kadosh R.
        The roles of cortical oscillations in sustained attention.
        Trends Cogn Sci. 2015; 19: 188-195https://doi.org/10.1016/j.tics.2015.02.004
        • Friedel B.
        The effect of tramadol on the EEG and the electronystagmogram (author’s transl).
        Arzneimittelforschung. 1978; 28: 187-189